NYSE - Delayed Quote USD

Centene Corporation (CNC)

Compare
75.52 +0.74 (+0.99%)
At close: August 8 at 4:00 PM EDT
75.53 +0.01 (+0.01%)
After hours: August 8 at 5:56 PM EDT
Loading Chart for CNC
DELL
  • Previous Close 74.78
  • Open 74.86
  • Bid 75.49 x 900
  • Ask 76.84 x 900
  • Day's Range 74.86 - 76.35
  • 52 Week Range 60.83 - 81.42
  • Volume 2,247,388
  • Avg. Volume 4,026,696
  • Market Cap (intraday) 39.726B
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 14.22
  • EPS (TTM) 5.31
  • Earnings Date Oct 25, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 85.89

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

www.centene.com

67,700

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CNC

View More

Performance Overview: CNC

Trailing total returns as of 8/8/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CNC
1.77%
S&P 500
11.52%

1-Year Return

CNC
13.00%
S&P 500
17.72%

3-Year Return

CNC
13.05%
S&P 500
19.90%

5-Year Return

CNC
54.25%
S&P 500
84.44%

Compare To: CNC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CNC

View More

Valuation Measures

Annual
As of 8/8/2024
  • Market Cap

    39.73B

  • Enterprise Value

    37.14B

  • Trailing P/E

    14.22

  • Forward P/E

    10.99

  • PEG Ratio (5yr expected)

    0.77

  • Price/Sales (ttm)

    0.26

  • Price/Book (mrq)

    1.45

  • Enterprise Value/Revenue

    0.24

  • Enterprise Value/EBITDA

    6.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.96%

  • Return on Assets (ttm)

    3.78%

  • Return on Equity (ttm)

    10.59%

  • Revenue (ttm)

    144.06B

  • Net Income Avi to Common (ttm)

    2.82B

  • Diluted EPS (ttm)

    5.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.21B

  • Total Debt/Equity (mrq)

    64.20%

  • Levered Free Cash Flow (ttm)

    1.97B

Research Analysis: CNC

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

74.00
85.89 Average
75.52 Current
96.00 High
 

Company Insights: CNC

Research Reports: CNC

View More
  • Centene Earnings: Individual Plan Growth Offsets Medicaid Redetermination Effects

    Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

    Rating
    Price Target
     
  • Argus Quick Note: Weekly Stock List for 05/20/2024: Companies Raising Guidance

    Management's ability to "raise guidance" can often be a catalyst for market-beating returns in the quarters ahead. The first-quarter earnings season has crossed the 90% mark and is wrapping up, with blended earnings (actual results and the consensus for those still to report) showing a year-over-year gain of almost 7%, according to Refinitiv. That is considerably better than the 4%-7% advance expected at the start of the earnings period. Leading the outperformance were strong gains in Communication Services earnings, up 43%, and Consumer Discretionary, up 26%. On the flipside, Healthcare and Energy, both down 24%, are performing the worst. Our analysts are always on the lookout for companies that boost outlooks during earnings season, as this is often a signal for momentum in the months ahead. Here is an initial list of BUY-rated companies in the Argus Fundamental Universe of Coverage at which management raised guidance or increased its outlook during the 1Q24 EPS reporting season.

     
  • Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

    In this edition, we assess exposure of some consumer finance banks; Compass Minerals puts its dividend on ice; Humana's stock pitch shows a rare opportunity; and Enel SpA, Warner Bros. Discovery, and Puma.

     
  • Company raises guidance

    Centene is an international healthcare company. Based in St. Louis, Centene offers services to government-sponsored and commercial healthcare providers, with an emphasis on underinsured and uninsured individuals. It is the largest Medicaid managed care organization in the U.S. and a leading provider of insurance under the Affordable Care Act. Its Specialty Services segment provides a range of healthcare products and services to managed care members and other customers.

    Rating
    Price Target
     

People Also Watch